 Immunoglobulin E
"Immunoglobulin E" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE).
| Descriptor ID |
D007073
|
| MeSH Number(s) |
D12.776.124.486.485.114.619.312 D12.776.124.790.651.114.619.312 D12.776.377.715.548.114.619.312
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunoglobulin E".
Below are MeSH descriptors whose meaning is more specific than "Immunoglobulin E".
This graph shows the total number of publications written about "Immunoglobulin E" by people in this website by year, and whether "Immunoglobulin E" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 4 | 2 | 6 | | 1997 | 1 | 2 | 3 | | 1998 | 0 | 1 | 1 | | 1999 | 1 | 4 | 5 | | 2001 | 2 | 3 | 5 | | 2002 | 2 | 2 | 4 | | 2003 | 4 | 5 | 9 | | 2004 | 2 | 4 | 6 | | 2005 | 4 | 2 | 6 | | 2006 | 2 | 7 | 9 | | 2007 | 2 | 2 | 4 | | 2008 | 0 | 6 | 6 | | 2009 | 4 | 6 | 10 | | 2010 | 4 | 7 | 11 | | 2011 | 2 | 5 | 7 | | 2012 | 2 | 9 | 11 | | 2013 | 2 | 8 | 10 | | 2014 | 4 | 8 | 12 | | 2015 | 5 | 7 | 12 | | 2016 | 5 | 3 | 8 | | 2017 | 0 | 16 | 16 | | 2018 | 1 | 5 | 6 | | 2019 | 4 | 4 | 8 | | 2020 | 1 | 10 | 11 | | 2021 | 4 | 2 | 6 | | 2022 | 0 | 4 | 4 | | 2023 | 2 | 7 | 9 | | 2024 | 5 | 8 | 13 | | 2025 | 2 | 4 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunoglobulin E" by people in Profiles.
-
Wang E, Henley W, Larenas-Linnemann D, Bulathsinhala L, Tran TN, Wechsler ME, Aaron SD, Al-Ahmad M, Al-Lehebi R, Altraja A, Barker P, Beastall A, Belevskiy AS, Bergeron C, Bjermer L, Björnsdóttir US, Bosnic-Anticevich SZ, Bourdin A, Brusselle GG, Busby J, Canonica GW, Carter V, Chapman KR, Chapman N, Christoff GC, Cosio BG, Costello RW, Fingleton J, Fonseca JA, Gaga M, Gibson PG, Hansen S, Heaney LG, Heffler E, Hew M, Horiguchi T, Hoyte F, Hubbard RB, Iwanaga T, Jackson DJ, Katial R, Koh MS, Kostikas K, Kuna P, Lehmann S, Lehtimäki L, Louis R, Lúdvíksdóttir D, Lugogo N, Mahboub B, Martin N, Máspero J, Menzies-Gow AN, Mohan A, Murray RB, Nagano T, Papadopoulos NG, Papaioannou AI, Patel PH, Perez-de-Llano L, Perng DW, Peters MJ, Pfeffer PE, Pitrez PM, Pleasants RA, Popov TA, Porsbjerg CM, Puggioni F, Quinton A, Rhee CK, Sadatsafavi M, Salvi S, Scioscia G, Sheu CC, Sirena C, Taillé C, Taube C, Torres-Duque CA, Tsai MJ, Tunsäter A, Ulrik CS, Price DB. Response to Biologics Along a Gradient of T2 Involvement in Patients With Severe Asthma: A Data-Driven Biomarker Clustering Approach. J Allergy Clin Immunol Pract. 2025 Dec; 13(12):3296-3315.
-
Hicks A, Friebert A, Venter C. Dietary and Nutritional Opportunities and Concerns for Patients with Food Allergy. Immunol Allergy Clin North Am. 2025 Aug; 45(3):429-444.
-
Braun C, Graham F, Fleischer DM, Molloy J, Bégin P, Eigenmann P. The Evolution of IgE-Based Allergy Testing in Atopic Dermatitis: Where Do We Stand? J Allergy Clin Immunol Pract. 2025 Aug; 13(8):1879-1886.
-
Leung C, Tang M, Finkbeiner WE, Johansson MW, Denlinger LC, Jarjour NN, Castro M, Sumino K, Erzurum SC, Comhair SA, Moore WC, Hastie AT, Levy BD, Israel E, Phillips BR, Mauger DT, Wenzel SE, Christenson S, Seibold MA, Jackson N, Woodruff PG, Fahy JV. Clinical and Biological Features of a Thickened Basement Membrane Zone in Asthma. Am J Respir Crit Care Med. 2025 May; 211(5):759-769.
-
Bernstein JS, Canon N, Schein CH, Braun W, Negi SS, Tchekmedyian R, Pozzoli M, Kim EH, Kulis MD, Vu T, Liu W, Chen X, Dreskin SC. Fine resolution of the N-terminal IgE-binding epitope of Ara h 2: Discovery of variants with enhanced IgE binding. J Allergy Clin Immunol. 2025 Aug; 156(2):385-393.
-
Duffus EK, Holguin F, Rastogi D. Non-T2 asthma. Curr Opin Pulm Med. 2025 May 01; 31(3):287-293.
-
Szefler S, Corren J, Silverberg JI, Okragly A, Sun Z, Natalie CR, Zitnik R, Siu K, Blauvelt A. Lebrikizumab decreases type 2 inflammatory biomarker levels in patients with asthma: data from randomized phase 3 trials (LAVOLTA I and II). Immunotherapy. 2024; 16(20-22):1211-1216.
-
Brough HA, Kim EH, Anagnostou A, Lanser BJ, Chinthrajah RS, Sindher SB. Treatment of Food Allergy: Immunotherapy, Omalizumab, or Both. J Allergy Clin Immunol Pract. 2025 Apr; 13(4):731-739.
-
Santos AF, Riggioni C, Agache I, Akdis CA, Akdis M, Alvarez-Perea A, Alvaro-Lozano M, Ballmer-Weber B, Barni S, Beyer K, Bindslev-Jensen C, Brough HA, Buyuktiryaki B, Chu D, Del Giacco S, Dunn-Galvin A, Eberlein B, Ebisawa M, Eigenmann P, Eiwegger T, Feeney M, Fernandez-Rivas M, Fiocchi A, Fisher HR, Fleischer DM, Giovannini M, Gray C, Hoffmann-Sommergruber K, Halken S, O'B Hourihane J, Jones CJ, Jutel M, Knol EF, Konstantinou GN, Lack G, Lau S, Mejias AM, Marchisotto MJ, Meyer R, Mortz CG, Moya B, Muraro A, Nilsson C, de Oliveira LCL, O'Mahony L, Papadopoulos NG, Perrett KP, Peters R, Podesta M, Poulsen LK, Roberts G, Sampson H, Schwarze J, Smith P, Tham E, Untersmayr E, Van Ree R, Venter C, Vickery B, Vlieg-Boerstra B, Werfel T, Worm M, Du Toit G, Skypala I. EAACI guidelines on the management of IgE-mediated food allergy. Allergy. 2025 Jan; 80(1):14-36.
-
Anagnostou A, Greenhawt M, Shaker M, Vickery BP, Wang J. Food allergy yardstick: Where does omalizumab fit? Ann Allergy Asthma Immunol. 2025 Jan; 134(1):110-121.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|